Electroshock therapy has long suffered from a controversial and bizarre public image, effectively removing it as a treatment option for many patients. In Electroshock, Max Fink, M.D., draws on 45 years of clinical and research experience to argue that ECT is now a safe, painless, and sometimes life-saving treatment for emotional and mental disorders. Dr. Fink traces the development of ECT from its discovery in 1934 followed by widespread use for two decades, to the 1950s when it was largely replaced by the introduction of psychotropic drugs, to its revival in the past twenty years as a viable treatment. He provides actual case studies of patients who have been treated with ECT and illustrates that many disorders--such as depression, mania, catatonia, and schizophrenia--respond well to it. As he explains the whole procedure from preparation to recovery, we see what the patient experiences. Fink also shows how anesthesia and muscle relaxation have refined ECT, minimizing discomfort and reducing risks to a level far lower than those experienced by patients using psychotropic drugs routinely prescribed for the same problems. Clarifying the many misconceptions surrounding ECT, Electroshock is an excellent sourcebook for patients, their families, and mental health professionals.
Electroshock therapy has long suffered from a controversial and bizarre public image, effectively removing it as a treatment option for many patients. In Electroshock, Max Fink, M.D., draws on 45 years of clinical and research experience to argue that ECT is now a safe, painless, and sometimes life-saving treatment for emotional and mental disorders. Dr. Fink traces the development of ECT from its discovery in 1934 followed by widespread use for two decades, to the 1950s when it was largely replaced by the introduction of psychotropic drugs, to its revival in the past twenty years as a viable treatment. He provides actual case studies of patients who have been treated with ECT and illustrates that many disorders--such as depression, mania, catatonia, and schizophrenia--respond well to it. As he explains the whole procedure from preparation to recovery, we see what the patient experiences. Fink also shows how anesthesia and muscle relaxation have refined ECT, minimizing discomfort and reducing risks to a level far lower than those experienced by patients using psychotropic drugs routinely prescribed for the same problems. Clarifying the many misconceptions surrounding ECT, Electroshock is an excellent sourcebook for patients, their families, and mental health professionals.
"A sourcebook for patients, their families, caretakers, and mental health professionals, Electroshock clarifies misconceptions about ECT."--BOOK JACKET.
Kitty Dukakis has battled debilitating depression for more than twenty years. Coupled with drug and alcohol addictions that both hid and fueled her suffering, Kitty's despair was overwhelming. She tried every medication and treatment available; none worked for long. It wasn't until she tried electroconvulsive therapy, or ECT, that she could reclaim her life. Kitty's dramatic first-person account of how ECT keeps her illness at bay is half the story of Shock. The other half, by award winning medical reporter Larry Tye, is an engrossing look at the science behind ECT and its dramatic yet subterranean comeback. This book presents a full picture of ECT, analyzing the treatment's risks along with its benefits. ECT, it turns out, is neither a panacea nor a scourge but a serious option for treating life threatening and disabling mental diseases, like depression, bipolar disorder, and others. Through Kitty Dukakis's moving narrative, and interviews with more than one hundred other ECT patients, Shock: The Healing Power of Electroconvulsive Therapy separates scare from promise, real complications from lurid headlines. In the process Shock offers practical guidance to prospective patients and their families, boldly addressing the controversy surrounding ECT and awakening millions to its capacity to heal.
This is a pioneering book about the use of ECT in adolescents who are diagnosed with severe, disabling psychiatric disorders or fail conventional treatment. Included are a review of the literature, firsthand experience of the authors and case descriptions making it an invaluable guide to treatment.
Prozac, Xanax, Halcion, Haldol, Lithium. These psychiatric drugs--and dozens of other short-term "solutions"--are being prescribed by doctors across the country as a quick antidote to depression, panic disorder, obsessive-compulsive disorder, and other psychiatric problems. But at what cost? In this searing, myth-shattering exposé, psychiatrist Peter R. Breggin, M.D., breaks through the hype and false promises surrounding the "New Psychiatry" and shows how dangerous, even potentially brain-damaging, many of its drugs and treatments are. He asserts that: psychiatric drugs are spreading an epidemic of long-term brain damage; mental "illnesses" like schizophrenia, depression, and anxiety disorder have never been proven to be genetic or even physical in origin, but are under the jurisdiction of medical doctors; millions of schoolchildren, housewives, elderly people, and others are labeled with medical diagnoses and treated with authoritarian interventions, rather than being patiently listened to, understood, and helped. Toxic Psychiatry sounds a passionate, much-needed wake-up call for everyone who plays a part, active or passive, in America's ever-increasing dependence on harmful psychiatric drugs.
Electroconvulsive therapy (ECT) is a psychiatric treatment involving the induction of a seizure through the transmission of electricity in the brain. Because of exploitation movies and greatly heightened drug company promotional activities ECT was used less frequently in the 1980s and 1990s. Eventually these movies were understood as unrealistic. Now these drugs are increasingly recognized as dangers to body health. Because of recent refinements and a far better scientific understanding of the clinical procedures and mechanisms underpinning ECT, this treatment modality has seen a resurgence in use and widespread appreciation of its safety. This book is the new definitive reference on electroconvulsive and neuromodulation therapies. It comprehensively covers the scientific basis and clinical practice of ECT as well as comparisons between ECT and medication therapies including the new generation of antipsychotic drugs. It also provides readers with administrative perspectives and specific details for the management of this modality in clinical practice. The new forms of nonconvulsive electrical and magnetic brain stimulation therapy are also covered in detail, in a separate section. The chapter authors are leading scholars and clinicians.
"A portion of this book was previously published in a different form in 'How a wooden bench in Zimbabwe is starting a revolution in mental health' by Alex Riley in Mosaic in 2018"--Copyright page.
Since the development of pharmacoconvulsive therapy in 1934 and of electroconvulsive therapy (ECT) in 1938, ECT has proven far more valuable than just the intervention of last resort. In comparison with psychotropic medications, we now know that ECT can act more effectively and more rapidly, with substantial clinical improvement that is often seen after only a few treatments. This is especially true for severely ill patients -- those with severe major depression with psychotic features, acute mania with psychotic features, or catatonia. For patients who are physically debilitated, elderly, or pregnant, ECT is also safer than psychotropic medications. The findings of the American Psychiatric Association (APA) Task Force on ECT were published by the APA in 1990 as the first edition of The Practice of Electroconvulsive Therapy, inaugurating the development of ECT guidelines by groups both within the United States and internationally. Since then, advances in the use of this technically demanding treatment prompted the APA to mandate a second edition. The updated format of this second edition presents background information followed by a summary of applicable recommendations for each chapter. This close integration of the recommendations with their justifications makes the material easy to read, understand, and use. To further enhance usability, recommendations critical to the safe, effective delivery of treatment are marked with the designation "should" to distinguish them from recommendations that are advisable but nonessential (with the designations "encouraged," "suggested," "considered"). The updated content of this second edition, which spans indication for use of ECT, patient evaluation, side effects, concurrent medications, consent procedures (with sample consent forms and patient information booklet), staffing, treatment administration, monitoring of outcome, management of patients following ECT, and documentation, as well as education, and clinical privileging. This volume reflects not only the wide expertise of its contributors, but also involved solicitation of input from a variety of other sources, including applicable medical professional organizations, individual experts in relevant fields, regulatory bodies, and major lay mental health organizations. In addition, the bibliography of this second edition is based upon an exhaustive search of the clinical ECT literature over the past decade and contains more than four times the original number of citations. Complemented by extensive annotations and useful appendixes, this remarkably comprehensive yet practical overview will prove an invaluable resource for practitioners and trainees in psychiatry and related disciplines.
Updated with bonus material, including a new foreword and afterword with new research, this New York Times bestseller is essential reading for a time when mental health is constantly in the news. In this astonishing and startling book, award-winning science and history writer Robert Whitaker investigates a medical mystery: Why has the number of disabled mentally ill in the United States tripled over the past two decades? Interwoven with Whitaker’s groundbreaking analysis of the merits of psychiatric medications are the personal stories of children and adults swept up in this epidemic. As Anatomy of an Epidemic reveals, other societies have begun to alter their use of psychiatric medications and are now reporting much improved outcomes . . . so why can’t such change happen here in the United States? Why have the results from these long-term studies—all of which point to the same startling conclusion—been kept from the public? Our nation has been hit by an epidemic of disabling mental illness, and yet, as Anatomy of an Epidemic reveals, the medical blueprints for curbing that epidemic have already been drawn up. Praise for Anatomy of an Epidemic “The timing of Robert Whitaker’s Anatomy of an Epidemic, a comprehensive and highly readable history of psychiatry in the United States, couldn’t be better.”—Salon “Anatomy of an Epidemic offers some answers, charting controversial ground with mystery-novel pacing.”—TIME “Lucid, pointed and important, Anatomy of an Epidemic should be required reading for anyone considering extended use of psychiatric medicine. Whitaker is at the height of his powers.” —Greg Critser, author of Generation Rx
